🇺🇸 FDA
Patent

US 8715529

Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use

granted A61KA61K47/554A61K49/0021

Quick answer

US patent 8715529 (Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use) held by Arrowhead Center, Inc. expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Center, Inc.
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/554, A61K49/0021, A61K49/0052